Breaking News - The Fly

Open Search

RNAZ

Transcode Therapeutics

$

()

Transcode Therapeutics Inc trading halted, news pending

RNAZ

12/3/2024 - 19:50pm

Transcode Therapeutics issues 21.2M shares at 37.7c in private placement

RNAZ

11/27/2024 - 07:15am

Transcode Therapeutics announces 1-for-33 reverse stock split

RNAZ

11/25/2024 - 07:03am

Transcode Therapeutics sends open letter to shareholders

RNAZ

11/12/2024 - 07:58am

Transcode Therapeutics announces Nasdaq extension to regain compliance

RNAZ

11/5/2024 - 07:21am

Transcode announces SRC approval of second cohort in Phase 1 TTX-MC138 trial

RNAZ

10/23/2024 - 07:08am

Transcode completes initial dosing of first cohort in trial with TTX-MC138

RNAZ

10/10/2024 - 07:03am

Transcode announces first patients treated in Phase 1 trial of TTX-MC138

RNAZ

9/17/2024 - 07:01am

Transcode Therapeutics announces publication of study on TTX-MC138

RNAZ

9/10/2024 - 07:04am

Transcode Therapeutics awarded $2M NIH grant to support TTX-MC138

RNAZ

9/5/2024 - 07:09am

Transcode Therapeutics announces Phase 1 trial initiation

RNAZ

8/15/2024 - 07:13am

Transcode Therapeutics 10M share Spot Secondary priced at 30c

RNAZ

7/23/2024 - 07:16am

Transcode Therapeutics announces common stock offering, no amount given

RNAZ

7/22/2024 - 16:09pm

Transcode Therapeutics regains compliance with Nasdaq listing requirements

RNAZ

6/10/2024 - 07:05am

Transcode Therapeutics reports data from FIH study of TTX-MC138

RNAZ

5/29/2024 - 09:16am